AXDX
Accelerate Diagnostics
AXDX
AXDX
Delisted
AXDX was delisted on the 14th of May, 2025.
117 hedge funds and large institutions have $679M invested in Accelerate Diagnostics in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 38 increasing their positions, 24 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
3% more funds holding
Funds holding: 114 → 117 (+3)
8% more call options, than puts
Call options by funds: $10.2M | Put options by funds: $9.47M
Holders
117
Holding in Top 10
5
Calls
$10.2M
Puts
$9.47M
Top Buyers
| 1 | +$30.3M | |
| 2 | +$9.38M | |
| 3 | +$7.16M | |
| 4 |
BlackRock
New York
|
+$6.12M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$4.97M |
Top Sellers
| 1 | -$10M | |
| 2 | -$6.43M | |
| 3 | -$1.26M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.17M |
| 5 |
AG
Artal Group
Luxembourg
|
-$1.14M |